NELL-1: Sanjeev Sethi, M.D., Ph.D.
Sanjeev Sethi, M.D., Ph.D., explains Mayo Clinic Laboratories’ newly developed test to detect neural epidermal growth factor-like 1 protein (NELL-1), a biomarker for membranous nephropathy (MN). The immunohistochemistry assay examines tissue samples for N
Episode 82 of the Answers from the Lab podcast, hosted by Mayo Clinic Laboratories, titled "NELL-1: Sanjeev Sethi, M.D., Ph.D." was published on June 15, 2021 and runs 17 minutes.
June 15, 2021 ·17m · Answers from the Lab
Summary
Sanjeev Sethi, M.D., Ph.D., explains Mayo Clinic Laboratories’ newly developed test to detect neural epidermal growth factor-like 1 protein (NELL-1), a biomarker for membranous nephropathy (MN). The immunohistochemistry assay examines tissue samples for NELL-1 antigen, which are found in 10% to 15% of MN patients. Discovered by Dr. Sethi in 2017, NELL-1 is the second most common antigen associated with MN and is correlated with underlying malignancy.
Episode Description
Similar Episodes
Apr 5, 2026 ·6m
Apr 2, 2026 ·5m
Mar 29, 2026 ·7m
Mar 19, 2026 ·5m
Mar 15, 2026 ·7m
Mar 9, 2026 ·12m